* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
© One World Science. All rights reserved
Meriva® is a trademark of Indena S.p.A
UC-II is a registered trademark of InterHealth N.I.
1 Gagnier JJ, van Tulder MW, Berman B, Bombardier C. Herbal medicine for low back pain. Spine. 2007; 32(1): 82-92.
2 Su S, Yua Y, Wang Y, Gu W, Zhou W, Duan J, Jiang H, Chen T, Tang Y. Evaluation of anti-inflammatory & analgesic properties of individual and combined extracts from commiphora myrrha and boswellia. J of Ethnophar. 2012; 193(2): 649-656.
3 Stewart K, Cole D. The commercial harvest of devil's claw in southern Africa: the devil's in the details. J of Ethnopharmacology. 2005; 100: 225-236.
4 Hoppe J. Curcuma: Turmeric. Medical Herbalism J for the Clin. Practitioner. 2001; 11(4): 3-5.
5 Epstein J, Sanderson IR, MacDonald TT. Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. British J of Nutrition. 2010; 103: 1545-1557.
6 Belcaro G, Cesarone M, Dugall M, Pellegrini L, Ledda A, Grossi M, Togni S, Appendino G. Efficacy and safety of Meriva, a complex curcumin-phosphatidlycholine complex, during extended administration in osteoarthritis patients. Alternative Medicine Review. 2010; 15(4): 337-344.
7 Anand P, Kunnumakkara A, Newman R, Aggarwal B. Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics. 2007; 4(6): 807-818.
8 Indena. Meriva bioavailable curcumin. http://www. Phytosomes.info. Accessed January 15, 2012.
9 Belcaro G, Cesarone M, Dugall M, Pellegrini L, Ledda A, Grossi M, Togni S, Appendino G. Product-Evaluation registry Meriva, curcumin-phosphatidylcholine complex, for complementary management of OA. Panminerva Medica. 2010; 52(2): 54-62.
10 Cuomo J, Appendino G, Dern A, Schneider E, McKinnon T, Brown M, Togni S, Dixon B. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J of Nat. Prod. 2011; 74: 664-669.
11 Heller L. Curcumin complex could provide arthritis benefits, Indena study. Nutra Ingredients. http://nutraingredients.com/content/view/print/313516. Accessed January 23, 2012.
12 Crowley DC, Lau FC, Sharma P, et al. Safety and efficacy of undenatured type II collagen in the treatment of OA of the knee: A clinical trial. International Journal of Med Sci. 2009; 6: 312-321.
13 Bagchi D, Misner B, Bagchi M, et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: Mechanistic exploration. Int J Clin Pharm Res. 2002; 22: 101-110.
14 Marone PA, Lau FC, Gupta RC, Bagchi M, Bagchi D. Safety and toxicological evaluations of undenatured type II collagen. Toxicol Mech Meth. 2010.
15 Burdock Group. Dossier in support of the generally recognized as safe (GRAS) status of UC?II? as a food ingredient. Internal data, 2009. Accessed March 12, 2012.
16 Setty AR, Sigal LH. Herbal medications commonly used in practice of rheumatology: Mechanisms of action, efficacay, and side effects. Seminars in Arthritis and Rheumatism. 2005; 773-784.
17 De Silva V, Metwally A, Ernst E, Lewith G, Macfarlane G. Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: A systematic review. Rheumatology. 2011; 50: 911-920.
18 Lawrence RM. The natural solution for arthritis sufferers and athletes. Total Health. 2004; 26(4): T24.
19 Appleton J. MSM joint health and beyond. Total Health. 2003; 25(1): S20-S21.
20 Nakhoostin-Roohi B, Barmaki S, Khoshkhahesh F, Bohlooli S. Effect of chronic supplementation of MSM on oxidative stress following acute exercise in untrained healthy men. J of Pharmacy & Pharmacology. 2011; 63: 1290-1294.
21 Pharmacy Update: Devil's claw. Chemist & Druggist. 2004; 19.
22 Wilkinson E. Review advises herbal remedies for back pain. Pulse. 2006; 14.
23 Mishra LC, Singh B. Scientific basis for therapeutic uses of guggul commiphora mukul. Topics in Clin Chiro. 2000; 7(2): 51-56.
24 Craig W. Myrrh: Nature's ancient anti-inflammatory agent. Vibrant Life. 2008; 24(2): 2-3.
25 Siemoneit U, Koeberle A, Rossi A, Dehm F, Verhoff M, Reckel S, Maier T, Jauch J, Northoff H, Bernhard F, et al Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory action of boswellic acids from frankincense. 2011; 162: 147-162.
26 Tawab M, Werz O, Zsilavecz M. Boswellia serrata an overall assessment of in vitro, preclinical and pharmacokinetic and clinical data. Clin Pharmacokinetics. 2011; 50(6): 349-369.